CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 772 shares at $24.67 ($19,045)
- 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 624 shares at $24.67 ($15,394)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 474 shares at $24.67 ($11,694)
- 4 Open-market sale CEO sold 5,577 shares at $24.67 ($137,585)
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale CEO sold 3,732 shares at $29.96 ($111,811)
- 4 Open-market sale EVP, COO, Head of Commercial sold 731 shares at $29.96 ($21,901)
- 4 Open-market sale EVP,General Counsel, Secretary sold 590 shares at $29.96 ($17,676)
- 4 Planned sale Principal Accounting Officer sold 2,000 shares at $28.30 ($56,600)
- 144 Insider Sale of Securities
- 4 Gift Director gave 2,918 shares (gift)
- 4 Open-market sale EVP, COO, Head of Commercial sold 4,960 shares at $22.64 ($112,294)
- 4 Open-market sale EVP, Chief Financial Officer sold 5,108 shares at $22.64 ($115,645)
Page 10 of 70 · 1,382 filings